Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
Merck KGaA offloads clinical-phase cancer drugs to Day One
Fierce Biotech
Tue, 02/23/21 - 10:45 am
Merck KGaA
Day One Biopharmaceuticals
pimasertib
solid tumors
Pieris finally vaults FDA hold on next-gen solid tumor hunter, clearing the path for mid-stage trial
Endpoints
Thu, 01/21/21 - 10:47 am
Pieris
FDA
solid tumors
BMS Kicks Off 2021 with $70 Million Collab for Next-Gen T Cell Cancer Therapies
BioSpace
Thu, 01/7/21 - 12:35 pm
Bristol-Myers Squibb
ArsenalBio
solid tumors
t-cell therapies
Oxford BioTherapeutics to research cell therapies for Gilead’s Kite
Pharmaforum
Thu, 01/7/21 - 11:28 am
Kite Pharma
Gilead Sciences
Oxford BioTherapeutics
solid tumors
blood cancer
cell therapy
Solid tumor biotech Silverback Therapeutics ups proposed deal size by 56% ahead of $195 million IPO
NASDAQ
Thu, 12/3/20 - 11:00 am
IPOs
Silverback Therapeutics
solid tumors
Seattle biotech firm Silverback Therapeutics aims for $100M IPO
Seattle Times, WA
Wed, 11/11/20 - 11:13 am
Silverback Therapeutics
IPOs
solid tumors
CTOS 2020 – Karyopharm seeks a solid tumour Seal of approval
EP Vantage
Mon, 11/2/20 - 11:01 pm
Karyopharm
solid tumors
Xpovio
CTOS
Sanofi to Evaluate THOR-707 with Merck's Checkpoint Inhibitor Keytruda
BioSpace
Thu, 10/29/20 - 12:14 pm
Sanofi
Merck
THOR-707
Keytruda
solid tumors
Exicure Announces Positive Phase Ib Trial Results for Solid Tumor Treatment
BioSpace
Thu, 09/17/20 - 11:01 pm
Exicure
solid tumors
cavrotolimod
clinical trials
Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors
Fierce Biotech
Wed, 09/2/20 - 11:13 am
Orca Bio
Lyell Immunopharma
R&D
solid tumors
cell therapy
Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up
BioPharma Dive
Thu, 08/27/20 - 10:11 pm
Foundation Medicine
FDA
cancer
liquid biopsy
diagnostics
solid tumors
pan-cancer
Poseida shares plunge after death in solid tumor CAR-T trial, clinical hold
Fierce Biotech
Tue, 08/18/20 - 11:05 pm
Poseida Therapeutics
solid tumors
CAR-T
SEC
prostate cancer
Roche pulls a tumor micro-environment drug out of the freezer, hands it to a UK upstart
Endpoints
Wed, 08/12/20 - 10:35 am
Roche
Celleron Therapeutics
solid tumors
Guardant scores FDA approval for liquid biopsy test
MedCity News
Mon, 08/10/20 - 10:52 am
Guardant Health
liquid biopsy
solid tumors
FDA
Tarveda’s Phase II Miniature Drug Conjugates Deliver Better Targeting, Less Toxicity than ADCs
BioSpace
Thu, 08/6/20 - 11:10 pm
Tarveda Therapeutics
miniature drug conjugates
Pentarin
oncology
solid tumors
Bolt Biotherapeutics nabs $93.5M to push Provenge inventor's new idea deeper in the clinic
Endpoints
Wed, 07/1/20 - 11:19 am
Bolt Biotherapeutics
funding
Provenge
solid tumors
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Fierce Pharma
Mon, 06/22/20 - 08:37 pm
Jazz Pharmaceuticals
solid tumors
cancer
Zepzelca
drug launches
Verastem Oncology announces preliminary data from investigator-initiated study highlighting clinical activity of RAF/MEK and FAK combination in KRAS mutant tumors
Pharmaceutical Business Review
Mon, 04/27/20 - 09:34 am
Verastem
clinical trials
VS-6766
solid tumors
AACR
Intensity Therapeutics signs clinical collaboration agreement with Bristol Myers Squibb for advanced solid tumors
Pharmaceutical Business Review
Wed, 04/15/20 - 10:47 am
Bristol-Myers Squibb
Intensity Therapeutics
INT230-6
Yervoy
solid tumors
One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis
Endpoints
Wed, 04/15/20 - 10:39 am
Novartis
drug discovery
solid tumors
immuno-oncology
Boston
startups
TScan
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »